76
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The Association Between Inflammatory and Oxidative Stress Biomarkers and Plasma Metabolites in a Longitudinal Study of Healthy Male Welders

ORCID Icon, , , ORCID Icon, , , , & show all
Pages 2825-2839 | Published online: 29 Jun 2021

References

  • Keyel PA. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. Cytokine. 2014;69(1):136–145. doi:10.1016/j.cyto.2014.03.007
  • Goldstein IM, Snyderman R, Gallin JI. Inflammation: Basic Principles and Clinical Correlates. Raven Press; 1992.
  • Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:10.1038/s41591-019-0675-0
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–867. doi:10.1038/nature05485
  • Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. doi:10.1161/01.cir.0000052939.59093.45
  • Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.
  • Devaraj S, Singh U, Jialal IJ. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol.2009;20(3):182.
  • Ridker PM, Buring JE, Cook NR, Rifai NJC. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391–397. doi:10.1161/01.cir.0000055014.62083.05
  • Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549–1564. doi:10.1161/CIRCRESAHA.119.315896
  • Marques-Vidal P, Velho S, Waterworth D, Waeber G, von Känel R, Vollenweider PJE. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used. Eur J Clin Nutr. 2012;66(4):426–435. doi:10.1038/ejcn.2011.170
  • van den Brink W, van Bilsen J, Salic K, et al. Current and future nutritional strategies to modulate inflammatory dynamics in metabolic disorders. Front Nutr.2019;6:129.
  • Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr., Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004;110(4):380–385. doi:10.1161/01.CIR.0000136581.59584.0E
  • Erlinger TP, Miller Iii ER, Charleston J, Appel LJJC. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation. 2003;108(2):150–154. doi:10.1161/01.CIR.0000080288.30567.86
  • Grundy SM. Inflammation, metabolic syndrome, and diet responsiveness. Am Heart Assoc. 2003;290(22):3000. doi:10.1001/jama.290.22.3000
  • Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635–645. doi:10.1016/j.cmet.2012.04.001
  • Wong JY, De Vivo I, Lin X, Fang SC, Christiani DC. The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One. 2014;9(1):e87348. doi:10.1371/journal.pone.0087348
  • Nuernberg AM, Boyce PD, Cavallari JM, Fang SC, Eisen EA, Christiani DC. Urinary 8-isoprostane and 8-OHdG concentrations in boilermakers with welding exposure. J Occup Environ Med. 2008;50(2):182–189. doi:10.1097/JOM.0b013e31815cf6cc
  • Gao S, Zhuo Z, Hutchinson J, Su L, Christiani DC. Metabolomic profiling identifies plasma sphingosine 1-phosphate levels associated with welding exposures. Occup Environ Med. 2020;oemed-2020-106918.
  • Bates D, Sarkar D, Bates MD, Matrix LJR. The lme4 package. Curr Drug Saf. 2007;2(1):74. doi:10.2174/157488607781668855
  • Baey C, Cournède P, Kuhn E. Asymptotic distribution of likelihood ratio test statistics for variance components in nonlinear mixed effects models. Computational Statistics and Data Analysis. 2019;135:107–122.
  • Benjamini Y, Hochberg YJ. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B.1995;57(1):289–300.
  • Haarman BCB, Riemersma-van der Lek RF, Nolen WA, Mendes R, Drexhage HA, Burger HJ. Feature-expression heat maps–A new visual method to explore complex associations between two variable sets. Journal of Biomedical Informatics. 2015;53:156–161.
  • Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla JJS. Package ‘corrplot’. Inorg Chem. 2017;56(316):e24. doi:10.1021/acs.inorgchem.7b00995
  • Johnson SC. Hierarchical clustering schemes. Psychometrika. 1967;32(3):241–254. doi:10.1007/BF02289588
  • Boyce GR, Shoeb M, Kodali V, et al. Welding fume inhalation exposure and high-fat diet change lipid homeostasis in rat liver. Toxicol Rep. 2020;7:1350–1355. doi:10.1016/j.toxrep.2020.10.008
  • Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15(8):511–523. doi:10.1038/nri3859
  • Wen H, Gris D, Lei Y, et al. Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12(5):408–415. doi:10.1038/ni.2022
  • Tall AR, Yvan-Charvet LJ. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15(2):104–116. doi:10.1038/nri3793
  • Barter PJ, Nicholls S, Rye K-A, Anantharamaiah G, Navab M, Fogelman AMJ. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764–772. doi:10.1161/01.RES.0000146094.59640.13
  • Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142(5):687–698. doi:10.1016/j.cell.2010.07.041
  • Kawakami M, Murase T, Ogawa H, et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem. 1987;101(2):331–338. doi:10.1093/oxfordjournals.jbchem.a121917
  • Wolsk E, Mygind H, Grøndahl TS, Pedersen BK, van Hall GJ. Metabolism. IL-6 selectively stimulates fat metabolism in human skeletal muscle. American J Physiol Endocrinol Metab. 2010;299(5):E832–E840. doi:10.1152/ajpendo.00328.2010
  • Rydén M, Dicker A, van Harmelen V, et al. Mapping of early signaling events in tumor necrosis factor-α-mediated lipolysis in human fat cells. J Bio Chem. 2002;277(2):1085–1091. doi:10.1074/jbc.M109498200
  • Milne GL, Yin H, Hardy KD, Davies SS, Roberts LJJ. Isoprostane generation and function. Chem Rev. 2011;111(10):5973–5996. doi:10.1021/cr200160h
  • Graille M, Wild P, Sauvain J, Hemmendinger M, Canu IG, Hopf NJTL. Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis. Toxicol Lett. 2020;328:19–27. doi:10.1016/j.toxlet.2020.04.006
  • Jourdan KB, Evans TW, Goldstraw P, Mitchell JA. Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release. FASEB J. 1999;13(9):1025–1030. doi:10.1096/fasebj.13.9.1025
  • Lustgarten MS, Fielding RAJ. Metabolites associated with circulating interleukin-6 in older adults. J Gerontol. 2017;72(9):1277–1283. doi:10.1093/gerona/glw039
  • Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100(1):96–102. doi:10.1161/01.cir.100.1.96
  • Lozanski G, Berthier F, Kushner IJBJ. The sphingomyelin–ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A but not a-Fibrinogen. 1997;328(1):271–275.
  • Fisslthaler B, Fleming IJ. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res. 2009;105(2):114–127. doi:10.1161/CIRCRESAHA.109.201590
  • Li Y, Sun R, Zou J, Ying Y, Luo Z. Dual roles of the AMP-activated protein kinase pathway in angiogenesis. Cells. 2019;8(7).
  • Stahmann N, Woods A, Spengler K, et al. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem. 2010;285(14):10638–10652. doi:10.1074/jbc.M110.108688
  • Ouchi N, Shibata R, Walsh K. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res. 2005;96(8):838–846. doi:10.1161/01.RES.0000163633.10240.3b
  • Reihill JA, Ewart MA, Hardie DG, Salt IP. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem Biophys Res Commun. 2007;354(4):1084–1088. doi:10.1016/j.bbrc.2007.01.110
  • Reihill JA, Ewart M-A, Salt IP. The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells. Vasc Cell. 2011;3(1):9. doi:10.1186/2045-824X-3-9
  • Ning Y, Manegold PC, Hong YK, et al. Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer. 2011;128(9):2038–2049. doi:10.1002/ijc.25562
  • Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem. 2009;284(10):6038–6042. doi:10.1074/jbc.C800207200
  • Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295